webinar register page

Integration of opioid use disorder and HIV treatment among persons involved in the justice system is not only smart, it is the right thing to do!
This session is part of NAHEWD's national webinar series Bridging HIV, HCV, and SUD: Innovations in the Field. The series will highlight various innovative models and approaches to treating substance use disorder (SUD) in people at risk for and living with HIV.

The speaker of this session will provide an overview of how integration of medication treatment for opioid use disorder can improve opioid outcomes as well as HIV treatment outcomes among those released from prison and jail. The learning objectives are:

Understand the changing epidemiology of opioid and other substance use disorders in the United States and relevance to those being released from prison and jail.

Understand the impact of opioid and other substance use on HIV epidemics in the United States.

Understand the importance of screening & diagnosis of opioid use disorder and initiation of FDA approved medication treatments for opioid use disorder in prisons and jails prior to release to the community, including use of newer longacting injectable formulations of medication treatment of opioid use disorder as a way to reduce overdose deaths and to prevent and treat HIV.

Oct 8, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
Loading

Speakers

Sandra A. Springer, MD
Associate Professor of Medicine, Section of Infectious Diseases, Yale School of Medicine @Yale AIDS Program
Dr. Springer is an Associate Professor of Medicine in the Department of Internal Medicine, Section of Infectious Diseases at the Yale School of Medicine. In addition, she is an attending Infectious Disease physician at the VA Connecticut Healthcare System and the Director of the Infectious Disease Clinic at the Newington VA site. She has significant clinical and research experience with persons with HIV and substance use disorders (SUDs) and is Board certified in Internal Medicine, Infectious Disease and Addiction Medicine. She is the Director of her research program InSTRIDE (Integrating Substance Use Treatment Research with Infectious Disease for Everyone) at Yale School of Medicine where she and her team conduct clinical research on the integration of SUDs and Infectious Disease/HIV treatments. She has focused on evaluating medication treatments for opioid and alcohol use disorders to improve substance use and ID/HIV treatment for persons involved with the criminal justice system.